Iterum Therapeutics plc (Nasdaq: ITRM) saw big hike in after-market with the news of New Drug Proposal to FDA
Hasnain Khan
December 3, 2020
Iterum Therapeutics plc (Nasdaq: ITRM) shares surged 39.31% to $0.9055 in the after-hours session, after a drug company involved in developing oral and IV antibiotics